Evaluating the cost-effectiveness of interventions designed to increase the utilization of evidence-based guidelines

Family Practice

Volumn 17, Issue SUPPL. 1, 2000, Pages

  Sculpher, Mark ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EDUCATION; CLINICAL STUDY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; MEDICAL AUDIT; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; RESOURCE ALLOCATION; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; DECISION TREES; EVALUATION STUDIES; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 0033982765     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Coulter A, Kelland J, Peto V, Rees MCP. Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice. Int J Technol Assess Health Care 1995; 11: 456-471.
2. Dowie R. A review of research in the United Kingdom to evaluate the implementation of clinical guidelines in general practice. Fam Pract 1998; 15: 462-70.
3. Department of Health. Methods to Promote the Implementation of Research Findings in the NHS - Priorities for Evaluation. Report to the NHS Central Research and Development Committee. Leeds: Department of Health, 1995.
4. Mason J, Wood J, Freemantle N. Designing evaluations of interventions to change professional practice. J Health Serv Res Policy 1999; 4: 106-111.
5. Freemantle N, Wood J, Mason J. Evaluating Change in Professional Behavior: Issues in Design and Analysis. Centre for Health Economics Discussion Paper No. 171. York: CHE, University of York, 1999.
6. Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term 'cost effective' in medicine. N Engl J Med 1986; 314: 253-256.
7. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford University Press, 1997.
8. Magid D, Douglas JM, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996; 124: 389-399.
9. Burman WJ, Dalton CB, Cohn DL, Butler JRG, Reves RR. A cost-effectiveness analysis of directly observed therapy versus self-administered therapy for treatment of tuberculosis. Chest 1997; 112: 63-70.
10. Effective Health Care. The Management of Menorrhagia. Effective Health Care Bulletin No. 9. Leeds: Nuffield Institute for Health, University of Leeds, 1995.
11. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence-based medicine: what it is and what it isn't. Br Med J 1996; 312: 71-72.
12. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95-104.
13. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. Med Decision Making 1985; 5: 157-177.
14. Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 1990; 6: 57-75.
15. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness Analysis in Health and Medicine. New York: Oxford University Press, 1996.
16. Browman GP, Levine MN, Mohide EA, Hayward RSA, Pritchard KI, Gafni A et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995; 13: 502-512.
17. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999; 3: No 2.
18. Robinson MB, Thompson E, Black NA. Why is evaluation of the cost effectiveness of audit so difficult? The example of thrombolysis for suspected acute myocardial infarction. Qual Health Care 1998; 7: 19-26.